Skip to main content
Michael Reardon, MD, Thoracic Surgery, Houston, TX

Michael Joseph Reardon MD

Vascular Surgery, Cardiovascular Surgery


Professor of Cardiothoracic Surgery/ Allison Family Distiguished Chair of Cardiovascular Research

Join to view full profile
  • 6550 Fannin StreetSuite 1401Houston, TX 77030

  • Phone+1 713-441-5200

  • Fax+1 713-793-7428

Dr. Reardon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a board certified cardiothoracic surgeon with research and clinical interests in open and catheter treatments of structural heart disease, aortic disease and cardiac tumors.

Education & Training

  • Rice University, Jesse H. Jones School of Management
    Rice University, Jesse H. Jones School of ManagementCertificate, Medical and Healthcare Management, 2005
  • Texas Heart Institute
    Texas Heart InstituteResidency, Thoracic Surgery - Independent, 1983 - 1985
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Vascular Surgery - Independent, 1985
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Surgery, 1978 - 1983
  • Baylor College of Medicine
    Baylor College of MedicineClass of 1978, MD

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1978 - 2027
  • Thoracic and Cardiac Surgery
    American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

  • The Best Doctors in America Woodward/White Survey 1998-2013
  • America’s Top Doctors for Cancer Castle Connolly 2005-2023
  • CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.  
    Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Z..., NEJM, 5/2/2023
  • Transcatheter Aortic Valve Replacement in Low-Risk Patients with Bicuspid Aortic Valve Stenosis  
    John K Forrest, Basel Ramlawi, Neal S Kleiman, Stanley J Chetcuti, Hector I Michelena, Jeffrey A Skiles, Jeffrey J Popma, Michael J Reardon, JAMA Cardiology
  • Editorial Comment Does Orientation Matter?∗  
    Michael J Reardon, Neal S Kleiman, ScienceDirect

Books/Book Chapters

Abstracts/Posters

  • Fundamentals of valve repair and coronary artery bypass.
    Reardon MJ, Baylor college of medicine cardiology fellowship lecture series
  • Clinical characteristics of patients needing bilateral carotid endarterectomy for advanced carotid atherosclerosis.
    Naveed Iqbal, Addison A. Taylor, Joel D. Morrisett, michael Reardon, William Insull, American heart association scientific sessions
  • The fellows spoke: the results of the national survey on spinal cord protection in the era of thoracic aortic stent grafting.
    Mussa FF, Huynh TT, Reardon MJ, Lumsden AB, Annual meeting of american college of surgeons south texas section, Houston, Texas

Lectures

  • Concomitant Valve Disease Management: Patient-tailored Therapy for the Intermediate Risk Patient 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Other

Authored Content

  • ACCEL Lite: Evolut Low-Risk Trial: 5-Year Data OutcomesApril 2025
  • Transcatheter Aortic Valve Replacement in Patients with Severe Mitral or Tricuspid Regurgitation at Extreme Risk for SurgeryJanuary 2018

Press Mentions

  • TAVR vs Surgery in Low-Risk Patients: 7-Year Outcomes Show Equivalent Results
    TAVR vs Surgery in Low-Risk Patients: 7-Year Outcomes Show Equivalent ResultsNovember 6th, 2025
  • Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial
    Sapien M3 TMVR Easily Beats Expectations in Pivotal TrialOctober 29th, 2025
  • PARTNER 3 Update: TAVR Still Comparable to SAVR in Low-Risk Patients After 7 Years
    PARTNER 3 Update: TAVR Still Comparable to SAVR in Low-Risk Patients After 7 YearsOctober 27th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: